Updated:
Eisai Co
Eisai Co serves as the single-family office for the founding family of Eisai Co., Ltd., the Tokyo-based pharmaceutical company established in 1941.
Eisai Co
Eisai Co serves as the single-family office for the founding family of Eisai Co., Ltd., the Tokyo-based pharmaceutical company established in 1941. The family office is headquartered in Woodcliff Lake, New Jersey, with additional offices in Manchester, UK, and Salt Lake City, Utah. The wealth originates from the founders' stake in the global pharmaceutical business focused on neurology and oncology (per public record). The family office deploys capital across a diversified mix including private credit, real estate, and healthcare services, with a focus on direct investments and co-investments alongside external managers. Its geographic footprint covers North America and Europe, with specific exposure to the UK and US markets. The portfolio includes direct real estate holdings in the Northeast US and private credit positions through structured debt instruments. Team size and total assets under management are not publicly disclosed. The office maintains a lean operational structure with professionals across its three locations. No philanthropic foundation or adjacent operating vehicles have been publicly identified. Eisai Co is structurally distinct as a hybrid of corporate investment arm and traditional family office, reflecting the founding family's ongoing ties to the pharmaceutical business. Its multi-continent footprint allows for cross-border deal sourcing in healthcare and real estate.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Woodcliff Lake
Corporate office
Woodcliff Lake, NJ, United States
Additional offices
Manchester, United Kingdom · Salt Lake City, UT, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Eisai Co?
Investment leadership at Eisai Co is not publicly disclosed, as the family office operates with a relatively low profile. The firm's structure suggests decisions are managed by senior family members and a small team of investment professionals.
How does Eisai Co source proprietary deal flow?
Eisai Co leverages the founding family's connections in the pharmaceutical and healthcare sectors for deal sourcing, supplemented by relationships with external managers in private credit and real estate. The family office's multi-region presence provides access to opportunities in both the US and UK markets.
What investment stages does Eisai Co typically target?
Eisai Co focuses on direct investments and co-investments, with a preference for private credit and real estate assets that offer stable, income-generating returns. The family office does not publicly disclose specific stage preferences but appears to favor mature, cash-flow-positive opportunities.
Is Eisai Co structured as a single family office or does it operate more like a private equity firm?
Eisai Co is structured as a single-family office, managing the wealth of the founding family of Eisai Co., Ltd. It does not operate as a private equity firm or raise external capital from third-party investors.
What is Eisai Co's relationship to Eisai Co., Ltd., the pharmaceutical company?
Eisai Co serves as the family office for the founding family of Eisai Co., Ltd., a global pharmaceutical company. The family office manages the wealth generated from the family's ownership stake in the pharmaceutical business, but operates as a separate legal and investment entity.
Which sectors does Eisai Co explicitly avoid?
Eisai Co has not publicly disclosed any sectors it avoids. However, given the family's background in pharmaceuticals and the office's focus on healthcare services, real estate, and private credit, it likely avoids high-risk, early-stage venture investments in unrelated industries.
Does Eisai Co maintain philanthropic structures, and how are they separated?
No philanthropic foundations or charitable vehicles have been publicly identified for Eisai Co. The family office's philanthropic activities, if any, are not disclosed and likely managed separately from the investment portfolio.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: